Neurodevelopmental outcome of acute bilirubin encephalopathyy

Journal of Tropical Pediatrics

Volumn 56, Issue 5, 2010, Pages 333-336

  Mukhopadhyay, Kanya ^a   Chowdhary, Gurdev ^a   Singh, Paramjeet ^a   Kumar, Praveen ^a   Narang, Anil ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Acute bilirubin encephalopathy; BERA; DDST; Exchange transfusion; MRI; Neurodevelopmental outcome

Indexed keywords

BILIRUBIN;

ACUTE BILIRUBIN ENCEPHALOPATHY; ARTICLE; BILIRUBIN BLOOD LEVEL; BRAIN DISEASE; BRAIN STEM EVOKED RESPONSE AUDIOMETRY; CEREBRAL PALSY; CHILD; CHOREOATHETOSIS; CLINICAL ARTICLE; DENVER DEVELOPMENT SCREENING TEST; DEVELOPMENTAL DISORDER; DEVELOPMENTAL SCREENING; DISEASE ASSOCIATION; DOUBLE VOLUME EXCHANGE TRANSFUSION; EVOKED RESPONSE AUDIOMETRY; EXCHANGE BLOOD TRANSFUSION; FEMALE; GESTATIONAL AGE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MALE; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEWBORN; NEWBORN JAUNDICE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PHOTOTHERAPY; SYMPTOM; TREATMENT OUTCOME; AUDIOMETRY; BLOOD; BRAIN; CHILD DEVELOPMENT; COMPLICATION; ECHOENCEPHALOGRAPHY; EVOKED BRAIN STEM AUDITORY RESPONSE; FOLLOW UP; JAUNDICE, NEONATAL; KERNICTERUS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

AUDIOMETRY; BILIRUBIN; BRAIN; CEREBRAL PALSY; CHILD DEVELOPMENT; ECHOENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; JAUNDICE, NEONATAL; KERNICTERUS; MAGNETIC RESONANCE IMAGING; MALE; NEUROLOGIC EXAMINATION; TREATMENT OUTCOME;

EID: 77957860411     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmp142     Document Type: Article

References (25)

1. Allen SH, Diamond LK, Vaughn VC. Erythroblastosis fetalis: VI. Prevention of kernicterus. Am J Dis Child 1950;80:779-91.
2. Hsai DY, Allen FH, Gellis SS, et al. Serum bilirubin in relation to kernicterus. N Engl J Med 1952;247:668-71.
3. Hyman CB, Keaster J, Hanson V. CNS abnormalities after neonatal hemolytic disease or hyperbilirubinemia. Am J Dis Child 1969;117:395-405.
4. Mollison PL, Cuthbush M. A method of measuring the severity of a series of cases of hemolytic disease of the new-born. Blood 1951;6:777-88.
5. Newman TB, Maisels MB. Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. Pediatrics 1992;89:809-18.
6. Scheidt PC, Mellits E, Hardy JB, et al. Toxicity to bilirubin in neonates: infant development during the first year in relation to maximum neonatal serum bilirubin concentration. J Pediatr 1977;91:292-7.
7. Boggs T, Hardy J, Frazier T. Correlation of neonatal serum total bilirubin concentration and developmental status at age eight months: preliminary report from the collaborative project. J Pediatr 1967;71:553-60.
8. Rubin RA, Balow B, Fisch RO. Neonatal serum bilirubin levels related to cognitive development at ages 4 through 7 years. J Pediatr 1979;94:601-4.
9. Turkel SB, Guttenberg ME, Moynes DR, et al. Lack of identifiable risk factors for kernicterus. Pediatrics 1980;66:502-6.
10. Newman TB, Klebanoff MA. Neonatal hyperbilirubinemia and long-term outcome: another look at the Collaborative Perinatal Project. Pediatrics 1993;92:651-7.
11. Wolf MJ, Beunen G, Casaer P, et al. Extreme hyperbilirubinaemia in Zimbabwean neonates: neurodevelopmental outcome at 4 months. Eur J Pediatr 1997;156: 803-7.
12. Wolf MJ, Wolf B, Beunen G, et al. Neurodevelopmental outcome at 1 year in Zimbabwean neonates with extreme hyperbilirubinaemia. Eur J Pediatr 1999;158:111-4.
13. Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breast-fed term neonates. Pediatrics 1995;96 (4 Pt 1):730-3.
14. Harris MC, Bernbaum JC, Polin JR, et al. Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. Pediatrics 2001;107:1075-80.
15. Newman TB, Liljestrand P, Escobar GJ. Infants with bilirubin levels of 30 mg/dL or more in a large managed care organization. Pediatrics 2003;111(6 Pt 1):1303-11.
16. Ip S, Glicken S, Kulig J, et al. Management of Neonatal Hyperbilirubinemia. Rockville, MD: US Department of Health and Human Services. Agency for Healthcare Research and Quality, 2003, AHRQ Publication No. 03-E011.
17. Johnson L, Bhutani VK, Karp K, et al. Clinical report from the Pilot USA Kernicterus Registry (1992-2004). J Perinatol 2009;29(Suppl 1):S25-45.
18. American Academy of Pediatrics, Subcommittee on hyperbilirubinemia. Clinical practice guideline: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114: 297-316.
19. Frankenburg WK. The Denver approach to early case finding. In: Frankenburg WK, Emde RN, Sullivan JW (eds). Early Identification of Children at Risk. New York, NY: Plenum Press, 1985; pp. 135-58.
20. Amiel-Tison C, Grenier A. Neurological Assessment During First Year of Life. New York: Oxford University Press, 1986; pp. 46-94.
21. Newman TB, Xiong B, Gonzales VM, Escobar GJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med 2000;154:1140-7.
22. Johnson L, Brown AK, Bhutani VK. BIND-a clinical score bilirubin induced neurologic dysfunction in neonates. Pediatr Suppl 1999;104:746.
23. Yilmaz Y, Degirmenci S, Akdas F, et al. Prognostic value of auditory brainstem response for neurologic outcome in patients with neonatal indirect hyperbilirubinemia. J Child Neurol 2001;16:772-5.
24. Shapiro SM, Nakumara H. Bilirubin and auditory system. J Perinatol 2001;21(Suppl 1): S52-5; discussion S59-62.
25. Katar S, Akay HO, Taskesen M, et al. Clinical and cranial magnetic resonance imaging (MRI) findings of 21 patients with serious hyperbilirubinemia. J Child Neurol 2008;23:415-7.